Press Releases :: Beyond Air Inc. (XAIR)

Beyond Air Receives Approval from Health Canada to Study Nitric Oxide Generated and Delivered by the LungFit™ in COVID-19 Patients

May 26, 2020 8:30am EDT

Beyond Air Achieves Primary Endpoint in Pilot Bronchiolitis Study

May 20, 2020 8:30am EDT

Beyond Air™ to Present New Data in an e-Poster Presentation at the Upcoming AACR Virtual Annual Meeting II on June 22nd to 24th

May 15, 2020 8:30am EDT

Beyond Air Enters into New Common Stock Purchase Agreement Extending Relationship with Lincoln Park Capital

May 15, 2020 8:25am EDT

Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States

Apr 16, 2020 8:30am EDT

Beyond Air Accelerates LungFit™ BRO COVID-19 Program

Mar 18, 2020 8:30am EDT

Beyond Air Submits Investigational Device Exemption (IDE) to the United States Food and Drug Administration (FDA) for the Treatment of COVID-19 Patients

Mar 16, 2020 8:00am EDT

Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET

Mar 05, 2020 9:00am EST

Beyond Air Hosting Analyst Day on March 5, 2020

Feb 25, 2020 8:30am EST

Beyond Air Reports Financial Results for Fiscal Third Quarter 2020

Feb 07, 2020 8:30am EST

1
2
3
4
5
6
7
8
9
10
...11

Important Safety Information

^†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.